Delivery Order SPE2DB22D3501-SPE2DB25FUT39
Award Date
2/28/25
Potential Completion Date
3/3/25
Potential Value
$5.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,966.87, is for the supply of Letrozole 2.5 mg tablets to support federal healthcare programs. The contract is a firm-fixed-price arrangement with a completion date of December 17, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,612.74, is for the delivery of Letrozole 2.5 mg tablets in 90-count packages. The contract is a Delivery Order type with a Firm Fixed Price pricing mechanism, and has an ultimate completion date of February 14, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,406.44, is for the delivery of Letrozole 2.5 mg tablets, a prescription medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Letrozole 2.5 mg tablets. The contract has a firm fixed price of $1,347.98 and a period of performance through February 26, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,153.64, is a Firm Fixed Price Delivery Order for the supply of 90-count bottles of the prescription drug Letrozole 2.5 mg tablets. The contract is part of a larger Indefinite Delivery Contract (IDC) the vendor holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $2,318.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order to supply 4566490525 - Letrozole 2.5 mg Tablets in 90-count packages. The award has an Ultimate Completion Date of November 20, 2024 and a Firm Fixed Price pricing type. This contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,045.56 firm fixed-price delivery order is for the supply of Letrozole 2.5 mg tablets, with an ultimate completion date of November 5, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of 4,566,403,935 tablets of the drug Letrozole 2.5 mg. The $14,750.91 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) and has a completion date of November 13, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,688.02 firm fixed-price delivery order is for the supply of 90-tablet bottles of the drug Letrozole 2.5 mg. The contract has a ceiling value of $9,688.02 and an ultimate completion date of May 21, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...
This federal contract award is for the supply of Letrozole 2.5 mg tablets to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,519.85, was awarded to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. This delivery order contract has a firm fixed price and is set to expire on August 30, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...